Search Within

Alexander Noor Shoushtari

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (28)
  3. Research Letter (5)
  4. Review (1)
Groups
  1. Department of Medicine (67)
  2. Epidemiology and Biostatistics (67)
  3. Hematologic Malignancies, Division of (67)
  4. Melanoma Disease Management Team (67)
  5. Melanoma and Immunotherapeutics Service (67)
  6. Solid Tumor Oncology Division (67)

More Groups

People
  1. Michael Postow (40)
  2. Katherine Panageas (34)
  3. Paul Chapman (32)
  4. Jedd Wolchok (31)
  5. Margaret Callahan (28)
  6. Parisa Momtaz (23)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (7)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. Clinical Cancer Research (4)
  3. JAMA Oncology (4)
  4. Annals of Surgical Oncology (3)
  5. Journal for ImmunoTherapy of Cancer (3)
  6. Cancer Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. American Association for Cancer Research (6)
  3. Nature Publishing Group (6)
  4. Springer (6)
  5. American Medical Association (4)
  6. Elsevier Inc. (4)

More Publishers

Results (67)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intracranial outcomes of ipilimumab and nivolumab in melanoma brain metastases after progression on anti-PD-1 therapy
    Research Letter

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Chen, M. F.; Momtaz, P.; Shoushtari, A. N.; Panageas, K. S.; Postow, M. A.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies
    Research Letter

    Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitor rechallenge after treatment with tumor-infiltrating lymphocytes in unresectable melanoma
    Meeting Abstract

    Betof Warner, A.; Smithy, J. W.; Los, C.; Kalvin, H.; Hasson, N.; Amaria, R. N.; Andrade Czapla, J. A.; Schollenberger, M.; furness, A.; Hassel, J. C.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A pilot trial of autologous tumor infiltrating lymphocytes (lifileucel, LN-144) for patients with asymptomatic melanoma brain metastases
    Meeting Abstract

    Warner, A. B.; Smithy, J. W.; Postow, M. A.; Panageas, K.; Schoenfeld, A. J.; Wolchok, J. D.; Shoushtari, A. N.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2 trial of IO102-IO103 and nivolumab-relatlimab fixed-dose combination in previously untreated, unresectable melanoma
    Meeting Abstract

    Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Das, J. P.; Lezcano, C.; Nair, S.; Lochrin, S. E.; Chen, M. F.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intracranial outcomes with ipilimumab and nivolumab in melanoma brain metastases following progression on anti-PD-1 therapy
    Meeting Abstract

    Lochrin, S. E.; Kalvin, H. L.; Smithy, J. W.; Momtaz, P.; Shoushtari, A. N.; Panageas, K.; Postow, M. A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline pathogenic variants in a large convenience cohort of multiple melanoma subtypes
    Meeting Abstract

    Lochrin, S. E.; Kemel, Y.; Stuart, J.; Smithy, J. W.; Mandelker, D.; Momtaz, P.; Chatila, W. K.; Schultz, N.; Postow, M. A.; Stadler, Z. K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
    Journal Article

    Barker, C. A.; D'Angelo, S. P.; Wasilewski, G.; Steckler, A. M.; Lian, M.; Zhang, Z.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Early on-treatment assessment of T cells, cytokines, and tumor DNA with adaptively dosed nivolumab + ipilimumab: Final results from the phase 2 ADAPT-IT study
    Journal Article

    Smithy, J. W.; Kalvin, H. L.; Ehrich, F. D.; Shah, R.; Adamow, M.; Raber, V.; Maher, C. A.; Kleman, J.; McIntyre, D. A. G.; Shoushtari, A. N.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Favorable toxicity and local control with ultrahypofractionated radiation therapy (UH-RT) for melanoma of the lower genital tract (LGT)
    Meeting Abstract

    Silver, B.; White, C.; Zhang, Z.; Shoushtari, A.; Leitao, M. M.; Williams, V. M.; Alektiar, K. M.; Kollmeier, M. A.
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save